Zhe Shao

15PUBLICATIONS
26CO-AUTHORS
Haematological tumoursTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 10, 2026
A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately.

|Jan 23, 2026
Targeting intratumoral regulatory T cells by CD137 aptamer-shRNA chimeras.

Kang Yi Lee, Yu Mei, Haiyan Liu

|Dec 24, 2024
Induction of cell death in malignant cells and regulatory T cells in the tumor microenvironment by targeting CD137.

Rui Sun, Kang Yi Lee, Yu Mei

|Dec 23, 2023
Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients.

Ulrich Räth, Patricia Mester, Herbert Schwarz

|Oct 27, 2022
Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype.

Rui Sun, Jia Le Lin, Man Si Cheng

|Dec 16, 2021
Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology.

Kilian Weigand, Georg Peschel, Jonathan Grimm

Pageof 3

Frequent Collaborators

3 joint publications

Christa Buechler

1 joint publications

Meihui Wu

1 joint publications

Radoslaw M Sobota

1 joint publications

Siew Cheng Wong